Recent Updates
Recently added Catalysts
SINT Positive Sentiment

MAXIM Group Resumes Coverage on SINTX Technologies with Buy Rating and $6 Price Target

Key Takeaway: MAXIM Group has resumed coverage on SINTX Technologies, assigning a Buy rating and a price target of $6. The report emphasizes SINTX's FDA-cleared SiNAPTIC® Foot & Ankle Osteotomy Wedge System and its expanding commercialization strategy. Analysts also noted the company's proprietary manufacturing capabilities and 3D-printing initiatives as key growth drivers.
Price reaction · baseline $2.22 (2026-06-04T14:41:00.000Z) · hit during market hours · clean, no other SINT news in the window
day 0 close · peak
+0.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • SINTX has an FDA-cleared product.
  • The company is expanding its commercialization strategy.
  • SINTX has proprietary manufacturing capabilities.
  • Analysts highlight growth potential in various applications.

Full Press Release Details

MAXIM Group Resumes Coverage on SINTX Technologies with Buy Rating and $6 Price Target
Independent analyst coverage highlights SINTX’s progress toward becoming a diversified silicon nitride biomaterials platform company, citing the company’s FDA-cleared SiNAPTIC® Foot & Ankle Osteotomy Wedge System, expanding commercialization strategy, and opportunities across orthopedic, antipathogenic, and patient-specific implant applications. The report also notes SINTX’s proprietary manufacturing capabilities, 3D-printing initiatives, and silicon nitride technology platform as potential drivers of future growth.

Frequently Asked Questions

What rating did MAXIM Group give SINTX Technologies?

MAXIM Group assigned a Buy rating to SINTX Technologies.

What is the price target for SINTX Technologies?

The price target set by MAXIM Group is $6.

What product was highlighted in the report?

The FDA-cleared SiNAPTIC® Foot & Ankle Osteotomy Wedge System was highlighted.

What growth opportunities does SINTX have?

SINTX has opportunities in orthopedic and patient-specific implant applications.

Last updated: Jun 4, 2026